Company
Headquarters: Jakarta Timur, Indonesia
Employees: 171
Rp645.35 Billion
IDR as of Jan. 1, 2026
US$38.6 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $102.42 B |
| Cencora, Inc. | $65.71 B |
| Cardinal Health, Inc. | $48.88 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $9.44 B |
| Henry Schein, Inc. | $9.32 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
PT Itama Ranoraya Tbk engages in the distribution of medical devices in Indonesia. The company offers Oneject auto disable syringe products, Abbott diagnostics products, Terumo BCT products, Ortho-clinical diagnostics, Becton Dickinson, iGene, and Diagast. It is also involved in building and office space rental business. The company was founded in 1989 and is headquartered in East Jakarta, Indonesia. PT Itama Ranoraya Tbk is a subsidiary of PT Global Dinamika Kencana.
PT Itama Ranoraya Tbk has the following listings and related stock indices.
Stock: IDX: IRRA wb_incandescent